Hofmeister V - Search Results

1

The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.

Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L, Weiss EH, Sauerbruch T, Spengler U. Nattermann J, et al. Among authors: hofmeister v. Am J Pathol. 2005 Feb;166(2):443-53. doi: 10.1016/S0002-9440(10)62267-5. Am J Pathol. 2005. PMID: 15681828 Free PMC article.

2

HLA-G modulates immune responses by diverse receptor interactions.

Hofmeister V, Weiss EH. Hofmeister V, et al. Semin Cancer Biol. 2003 Oct;13(5):317-23. doi: 10.1016/s1044-579x(03)00022-1. Semin Cancer Biol. 2003. PMID: 14708711 Review.

3

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.

Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Weiss EH, Dichgans J, Lochmuller H, Hohlfeld R, Melms A, Weller M. Wiendl H, et al. Among authors: hofmeister v. Brain. 2003 Jan;126(Pt 1):176-85. doi: 10.1093/brain/awg017. Brain. 2003. PMID: 12477705

4

HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.

Ulbrecht M, Hofmeister V, Yüksekdag G, Ellwart JW, Hengel H, Momburg F, Martinozzi S, Reboul M, Pla M, Weiss EH. Ulbrecht M, et al. Among authors: hofmeister v. Hum Immunol. 2003 Feb;64(2):231-7. doi: 10.1016/s0198-8859(02)00788-7. Hum Immunol. 2003. PMID: 12559625

5

Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands.

Ulbrecht M, Maier S, Hofmeister V, Falk CS, Brooks AG, McMaster MT, Weiss EH. Ulbrecht M, et al. Among authors: hofmeister v. Hum Immunol. 2004 Mar;65(3):200-8. doi: 10.1016/j.humimm.2003.12.004. Hum Immunol. 2004. PMID: 15041158

6

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.

Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A, Weller M. Wiendl H, et al. Among authors: hofmeister v. J Immunol. 2002 May 1;168(9):4772-80. doi: 10.4049/jimmunol.168.9.4772. J Immunol. 2002. PMID: 11971028

7

Tumor stroma-associated antigens for anti-cancer immunotherapy.

Hofmeister V, Vetter C, Schrama D, Bröcker EB, Becker JC. Hofmeister V, et al. Cancer Immunol Immunother. 2006 May;55(5):481-94. doi: 10.1007/s00262-005-0070-1. Epub 2005 Oct 12. Cancer Immunol Immunother. 2006. PMID: 16220326 Free PMC article. Review.

8

MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib.

Houben R, Voigt H, Noelke C, Hofmeister V, Becker JC, Schrama D. Houben R, et al. Among authors: hofmeister v. Mol Cancer Ther. 2009 Feb;8(2):433-40. doi: 10.1158/1535-7163.MCT-08-1051. Epub 2009 Feb 3. Mol Cancer Ther. 2009. PMID: 19190114

9

Anti-cancer therapies targeting the tumor stroma.

Hofmeister V, Schrama D, Becker JC. Hofmeister V, et al. Cancer Immunol Immunother. 2008 Jan;57(1):1-17. doi: 10.1007/s00262-007-0365-5. Epub 2007 Jul 27. Cancer Immunol Immunother. 2008. PMID: 17661033 Free PMC article. Review.

10

HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.

Nattermann J, Nischalke HD, Hofmeister V, Kupfer B, Ahlenstiel G, Feldmann G, Rockstroh J, Weiss EH, Sauerbruch T, Spengler U. Nattermann J, et al. Among authors: hofmeister v. Antivir Ther. 2005;10(1):95-107. doi: 10.1177/135965350501000107. Antivir Ther. 2005. PMID: 15751767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page